Semax Dosage and Protocols
Semax dosage protocols reported in published research, plus reconstitution and storage.
Research Protocol Doses Reported in Published Literature
Research Disclaimer: Doses reported below are from published preclinical research protocols. Semax is not approved for human use by the FDA or any regulatory agency. This information is provided for research reference only and does not constitute a dosing recommendation. All doses above are reported from published research protocols using laboratory subjects. Refer to the cited studies in the Research Studies section above for original source data.
Reported protocol doses
Reconstitution
A 10mg vial with 2mL of bacteriostatic water is the pairing reported most often. Often supplied as a nasal solution. As a 10mg vial + 2mL = 5000mcg/mL, a 300mcg dose is ~3 drops depending on dropper calibration.
Work out your own concentration with the reconstitution calculator.
Doses shown are those reported in published research, not a recommendation.
References
- Semax, an ACTH(4-10) analogue, and brain BDNF expression
- Dergunova LV, Filippenkov IB, Stavchansky VV, et al. Novel insights into the protective properties of ACTH(4-7)PGP (Semax) peptide at the transcriptome level following cerebral ischaemia-reperfusion in rats. Genes (Basel). 2020;11(6):681.
- [Results of the application of complex physiotherapeutic neurostimulation in optical neuropathies of various genesis].
- The peptide semax affects the expression of genes related to the ...
- Functional Connectomic Approach to Studying Selank and Semax Effects.
- [Evaluation of therapeutic effect of new Russian drug semax in optic ...